Targeting the tumor vascular compartment to improve conventional cancer therapy

Trends in Pharmacological Sciences
Olivier Feron

Abstract

The fact that a single blood vessel can support the life of thousands of tumor cells has been known for a long time. However, therapeutic strategies that aim to impair vascular development in tumors are only slowly emerging in the clinics. Nevertheless, the accumulation of data from many successful preclinical studies of the effects of a variety of drugs that target tumor vasculature provides clues that should help rationalize future treatment modalities for human tumors. Indeed, the 'old' view of an immature and non-functional vascular network within tumors has evolved and, in this article, we will show that the concept of tumor heterogeneity should be extended to the vascular compartment. In addition, we will review recent data documenting that both mature and immature vessels coexist within tumors and, importantly, that their relative density responds to a dynamic process that evolves with time and treatments.

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Dec 6, 1997·Nature·R S Kerbel
Jan 1, 1999·Nature·C LengauerB Vogelstein
Sep 30, 1999·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·B GallezP D Misson
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Aug 19, 2000·Science·B St CroixK W Kinzler
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Oct 18, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D W SiemannM R Horsman
Feb 23, 2002·Science·Joanne L YuRobert S Kerbel
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jennifer TranRobert S Kerbel
Jul 27, 2002·Science·Ester M Hammond, Amato J Giaccia
Oct 25, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pierre SonveauxOlivier Feron
Jan 1, 2003·The American Journal of Pathology·Michael S GeeWilliam M F Lee
Jun 5, 2003·Nature Medicine·Rakesh K Jain
Oct 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Guido BocciRobert S Kerbel
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philip E Thorpe
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar

❮ Previous
Next ❯

Citations

Jun 4, 2010·Science Translational Medicine·Olivier Feron
Nov 10, 2009·Expert Review of Anticancer Therapy·Bristi BasuPippa Corrie
Jun 23, 2009·Expert Opinion on Drug Delivery·Bei ChenKaichun Wu
Jan 18, 2008·Journal of Pharmaceutical Sciences·Ales Prokop, Jeffrey M Davidson
Jan 21, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pierre SonveauxOlivier Feron
Mar 4, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Pierre Sonveaux
Jul 9, 2009·International Journal of Cancer. Journal International Du Cancer·Jérome SegersBernard Gallez
Apr 25, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Caroline Bouzin, Olivier Feron
Nov 26, 2015·Progress in Nuclear Magnetic Resonance Spectroscopy·Kay M PepinKiaran P McGee
Jan 13, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christophe F ChantrainEtienne Marbaix
Nov 15, 2011·Bioorganic & Medicinal Chemistry·María Isabel García-ArandaMaría Jesús Pérez de Vega
Mar 15, 2015·Organic & Biomolecular Chemistry·Ahmed KamalVunnam Srinivasulu
May 29, 2016·Cancer Letters·Yong XinGuan Jiang
Jul 14, 2012·British Journal of Cancer·W T TranG J Czarnota
Jan 18, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Huiru LiJianhao Zhao
Feb 6, 2013·Organic & Biomolecular Chemistry·María Isabel García-ArandaMaría Jesús Pérez de Vega
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xin YaoBin Tean Teh
Jul 24, 2021·Neoplasia : an International Journal for Oncology Research·Hiba GhuraInaam A Nakchbandi
May 26, 2006·Journal of Medicinal Chemistry·Daniele SimoniClaudio Pisano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.